EUVIMEDEUVIMED entdecken
Crossref

Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury

Jiaqi Li, Shuang Chen, Jialiang Suo, Yuanbiao Ma, Zhengxin Lu, Shenlin Cai, Haoyu Chen, Zhiyu Chen, Zhewen Deng, Chenglun Tang, Qi Zhang, Bo Ma

Molecular Immunology · 2026-08 · 196 · 133-147

DOI: 10.1016/j.molimm.2026.06.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Immunology, 2026-08. Verfasst von Jiaqi Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, People's Republic of China. Hauptthemen laut MEDLINE: Podocytes, Diabetic Nephropathies, Autophagy, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, effective therapeutic strategies to halt the irreversible decline of renal function in diabetic nephropathy (DN) are limited. This study aimed to investigate the renoprotective effects of Cordycepin (COR), a bioactive adenosine analog derived from Cordyceps militaris, in a mouse model of DN and to elucidate its underlying mechanisms. In a type II diabetic mouse model induced by a high-fat diet and streptozotocin, COR treatment attenuated hyperglycemia and renal dysfunction, ameliorated glomerular injury, and restored the expression of Nephrin, a critical slit-diaphragm protein in podocytes. In vitro, in palmitic acid (PA)-induced podocyte injury, COR treatment elevated cell viability and upregulated Nephrin expression dose-dependently. Mechanistically, COR restored impaired autophagic flux under diabetic conditions by improving autophagosome maturation, autophagosome-lysosome fusion, and lysosomal degradation, as demonstrated by the normalized profile of autophagy markers (LC3-II/I, p62, Beclin-1, LAMP1). This pro-autophagic activity was essential for its protection, which was abolished by 3-MA and enhanced by rapamycin. Subsequently, we identified transcription factor EB (TFEB) as the central mediator of COR's action. COR dually regulates TFEB through two synchronized pathways: it inhibits the mTORC1 axis to promote TFEB nuclear translocation and transcriptional activity, while simultaneously suppressing K48-linked polyubiquitination to prevent its proteasomal degradation, and enhancing its stability. TFEB was essential for restoring autophagic flux and podocyte integrity, with overexpression reversing and knockdown exacerbating PA‑induced injury. In summary, our findings demonstrate that COR alleviates DN by coordinately enhancing the activity and stability of TFEB. This work reveals a novel dual-targeting mechanism and proposes a promising therapeutic strategy for diabetic nephropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesDiabetic NephropathiesAutophagyBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsDeoxyadenosinesAnimalsMiceSignal TransductionMaleMice, Inbred C57BLDiabetes Mellitus, ExperimentalMembrane Proteins

Stichwörter der Autor:innen

Autophagy FluxCordycepin (COR)Diabetic nephropathy (DN)PodocyteTFEB

Substanzen

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorscordycepinDeoxyadenosinesTcfeb protein, mousenephrinMembrane Proteins

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, People's Republic of China.
  • Nanjing Sheng Ming Yuan Health Technology Co. Ltd., Nanjing 210000, People's Republic of China.
  • School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, People's Republic of China. Electronic address: zhangqi@njtech.edu.cn.
  • School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211816, People's Republic of China. Electronic address: mabo201012@njtech.edu.cn.

Zitieren

APA

Li, J., Chen, S., Suo, J., Ma, Y., Lu, Z., Cai, S., Chen, H., Chen, Z., Deng, Z., Tang, C., Zhang, Q., & Ma, B. (2026). Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury. Molecular Immunology, 196, 133-147. https://doi.org/10.1016/j.molimm.2026.06.010

Vancouver

Li J, Chen S, Suo J, Ma Y, Lu Z, Cai S, et al. Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury. Molecular Immunology. 2026;196:133-147. doi:10.1016/j.molimm.2026.06.010

BibTeX
@article{Li2026,
  author = {Li, Jiaqi and Chen, Shuang and Suo, Jialiang and Ma, Yuanbiao and Lu, Zhengxin and Cai, Shenlin and Chen, Haoyu and Chen, Zhiyu and Deng, Zhewen and Tang, Chenglun and Zhang, Qi and Ma, Bo},
  title = {Cordycepin attenuates diabetic nephropathy by dual-pathway activation of TFEB to restore autophagy and ameliorate podocyte injury},
  journal = {Molecular Immunology},
  year = {2026},
  volume = {196},
  pages = {133--147},
  doi = {10.1016/j.molimm.2026.06.010}
}
Kostenlos starten →